171 related articles for article (PubMed ID: 36902135)
1. Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities.
Jaksic Karisik M; Lazarevic M; Mitic D; Nikolic N; Milosevic Markovic M; Jelovac D; Milasin J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902135
[TBL] [Abstract][Full Text] [Related]
2. CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction.
Patil S; Al-Brakati A; Abidi NH; Almasri MA; Almeslet AS; Patil VR; Raj AT; Bhandi S
Med Oncol; 2022 Jan; 39(2):23. PubMed ID: 34982245
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
Baglìo SR; Devescovi V; Granchi D; Baldini N
Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
5. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
6. Space microgravity drives transdifferentiation of human bone marrow-derived mesenchymal stem cells from osteogenesis to adipogenesis.
Zhang C; Li L; Jiang Y; Wang C; Geng B; Wang Y; Chen J; Liu F; Qiu P; Zhai G; Chen P; Quan R; Wang J
FASEB J; 2018 Aug; 32(8):4444-4458. PubMed ID: 29533735
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of a subpopulation of CD133
Ma Z; Zhang C; Liu X; Fang F; Liu S; Liao X; Tao S; Mai H
Sci Rep; 2020 Jun; 10(1):8875. PubMed ID: 32483269
[TBL] [Abstract][Full Text] [Related]
8. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
9. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
10. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
11. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
13. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
14. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
[TBL] [Abstract][Full Text] [Related]
16. Role of miRNA dynamics and cytokine profile in governing CD44v6/Nanog/PTEN axis in oral cancer: modulating the master regulators.
Patel S; Rawal R
Tumour Biol; 2016 Nov; 37(11):14565-14575. PubMed ID: 27612478
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
[TBL] [Abstract][Full Text] [Related]
20. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
Mărgăritescu C; Pirici D; Simionescu C; Stepan A
Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]